René Vollenbroich

  • Citations Per Year
Learn More
OBJECTIVES This study sought to summarize available evidence on transcatheter aortic valve replacement (TAVR) for the treatment of native pure aortic regurgitation (AR). BACKGROUND Surgical aortic valve replacement (SAVR) is the gold standard for the treatment of AR. However, case series of high-risk patients undergoing TAVR for native pure AR were(More)
BACKGROUND Among patients undergoing transcatheter aortic valve implantation (TAVI), concomitant mitral regurgitation (MR) has been associated with adverse prognosis. We aimed to assess long-term clinical outcomes according to MR etiology. METHODS In a single-center registry of consecutive patients undergoing TAVI, we investigated the impact of functional(More)
☆ Institution where work was performed: University Cardiology, Bern, Switzerland. ☆☆ Prof. Dr.Meier reports research grants to the institutio Medical. Prof. Dr. Pilgrim reports grants to the institution from Medtronic and Biotronik. ⁎ Corresponding author at: University Hospital Be Switzerland. E-mail address: rene.vollenbroich@insel.ch (R. Vollen 1(More)
AIMS The aim of the study was to evaluate the prognostic utility of right heart catheterisation (RHC)-derived measures among patients undergoing transcatheter aortic valve implantation (TAVI). METHODS AND RESULTS Data of 469 patients included in the Bern TAVI Registry between August 2007 and December 2012 and undergoing preoperative RHC were analysed. The(More)
  • 1